Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • ARRAY BIOPHARMA INC Balance Sheet

  • View:
    Annual Data | Quarterly Data
    Period Ending FY2009 FY2008 FY2007 FY2006 FY2005
    Assets
    Cash and Short Term Investments 40.50 M 95.69 M 141.33 M 70.10 M 92.71 M
    Net Receivables 0.00 0.00 209,000.00 1.36 M 679,609.00
    Total Inventories 0.00 0.00 1.49 M 1.65 M 2.15 M
    Progress Payments & Others 0.00 0.00 -2.03 M -2.22 M -2.92 M
    Prepaid Expenses 727,000.00 707,000.00
    Other Current Assets 4.42 M 5.06 M 2.37 M 1.76 M 1.03 M
    Current Assets Total 44.92 M 100.75 M 145.40 M 74.86 M 96.56 M
    Long Term Receivables 0.00 0.00 0.00 0.00 0.00
    Investment in Unconsolidated Subsidiaries 0.00 0.00 0.00 0.00 0.00
    Other Investments 16.99 M 29.84 M 0.00 0.00 0.00
    Property, Plant & Equipment Net 26.50 M 30.16 M 28.08 M 27.31 M 31.31 M
    Property, Plant & Equipment Gross 83.68 M 80.88 M 72.96 M 66.14 M 61.52 M
    Accumulated Depreciation 57.18 M 50.72 M 44.89 M 38.83 M 30.21 M
    Other Assets 6.65 M 2.32 M 1.50 M 0.00 80,246.00
    Deferred Charges 0.00 0.00 0.00 0.00 0.00
    Tangible Other Assets 6.65 M 2.32 M 1.50 M 0.00 80,246.00
    Intangible Other Assets 0.00 0.00 0.00 0.00 0.00
    Total Assets 95.06 M 163.08 M 174.97 M 102.17 M 127.95 M
    Liabilities
    Short Term Debt & Current Portion of Long Term Debt 15.00 M 0.00 0.00 0.00 0.00
    Accrued Payroll 7.85 M 7.50 M 6.77 M 5.77 M 4.32 M
    Income Taxes Payable 0.00 0.00 0.00 0.00 0.00
    Dividends Payable 0.00 0.00 0.00 0.00 0.00
    Other Current Liabilities 20.97 M 22.24 M 7.72 M 6.87 M 8.10 M
    Current Liabilities Total 50.30 M 34.41 M 24.57 M 18.86 M 16.13 M
    Long Term Debt 68.17 M 35.36 M 15.00 M 14.15 M 10.00 M
    Provision for Risks & Charges
    Deferred Taxes 0.00 0.00 0.00 0.00 0.00
    Deferred Income 49.82 M 54.54 M 27.15 M 0.00 1.35 M
    Deferred Tax Liability in Untaxed Reserves
    Other Liabilities 470,000.00 751,000.00 557,000.00 526,671.00 1.05 M
    Total Liabilities 168.76 M 125.05 M 67.27 M 33.53 M 28.54 M
    Shareholders Equity
    Non-Equity Reserves 0.00 0.00 0.00 0.00 0.00
    Minority Interest 0.00 0.00 0.00 0.00 0.00
    Preferred Stock 0.00 0.00 0.00 0.00 0.00
    Common Equity -73.70 M 38.03 M 107.70 M 68.64 M 99.42 M
    Common Stock 48,000.00 48,000.00 47,000.00 39,124.00 38,467.00
    Capital Surplus 312.35 M 304.71 M 296.77 M 202.53 M 193.70 M
    Revaluation Reserves 0.00 0.00 0.00 0.00 0.00
    Other Appropriated Reserves 23.87 M 20.59 M 0.00 -151,004.00 -2.23 M
    Unappropriated (Free) Reserves 0.00 0.00 0.00 0.00 0.00
    Retained Earnings -413.20 M -285.39 M -189.10 M -133.65 M -94.04 M
    Equity in Untaxed Reserves
    ESOP Guarantees 0.00 0.00 0.00 0.00 0.00
    Unrealized Foreign Exchange Gain (Loss) 0.00 0.00 0.00 0.00 0.00
    Unrealized Gain (Loss) on Marketable Securities 3.23 M -1.94 M -15,000.00 -270,686.00 -279,098.00
    Treasury Stock 0.00 0.00 0.00 0.00 0.00
    Total Liabilities & Shareholders Equity 95.06 M 163.08 M 174.97 M 102.17 M 127.95 M
    Common Shares Outstanding 48.13 M 47.54 M 47.08 M 39.12 M 38.47 M